Group: sci.med.nursing

Nursing questions and discussion.

Add group to favorites Add group to favorites
   indietro Back to post list     indietro Send new message to group

Post Subject:

Bloodletting In NAFLD

Reply from: ironjustice
Date: 10 May, 02:34
"Phlebotomy offers a safe and efficient therapy"

American Journal of Clinical Nutrition, Vol. 87, No. 5, 1374-1383, May
2008
© 2008 American Society for Nutrition

----------------------------------------------------------------------------=
----

ORIGINAL RESEARCH COMMUNICATION

Pathways underlying iron accumulation in human nonalcoholic fatty
liver disease1,2,3
Elmar Aigner, Igor Theurl, Milan Theurl, Dieter Lederer, Heike Haufe,
Otto Dietze, Michael Strasser, Christian Datz and Guenter Weiss
1 From the Department of Internal Medicine, General Hospital
Oberndorf, Oberndorf, Austria (EA, DL, and CD); the Department of
General Internal Medicine, Department of Immunology and Infectious
Diseases, Medical University of Innsbruck, Austria (IT, MT, and GW);
the Department of Pathology (HH and OD) and the First Department of
Medicine (MS), Paracelsus Private Medical University Salzburg,
Austria


Background: Mild iron overload is frequently observed in nonalcoholic
fatty liver disease (NAFLD).

Objective: We aimed to study putative pathways underlying iron
accumulation in NAFLD.

Design: Hepatic and duodenal expression of critical iron molecules in
NAFLD patients with (n = 32) and without (n = 29) iron overload,
hereditary hemochromatosis (n = 10), and controls (n = 20) were
investigated. Phlebotomy treatment was performed in 14 NAFLD
patients.

Results: The hepatic expressions of the iron-export protein
ferroportin-1 (FP-1) and of the iron-sensing molecule hemojuvelin
(HJV) were significantly lower in NAFLD patients. The mRNA expression
of the iron-regulatory peptide hepcidin was increased in NAFLD
patients with iron overload, which was paralleled by low duodenal FP-1
expression. Hepatic mRNA and serum protein concentrations of tumor
necrosis factor- (TNF-) were increased in NAFLD patients and were
inversely correlated with both liver FP-1 and HJV mRNA and positively
associated with body mass index and hepatic hepcidin mRNA.
Accordingly, TNF- inhibited the FP-1 and HJV mRNA formation in HepG2
cells. Phlebotomy treatment of NALFD patients reduced serum ferritin,
transferrin saturation, and TNF- concentrations and improved liver
function tests.

Conclusions: Iron accumulation in NAFLD may result from an impaired
iron export due to down-regulation of FP1 and ineffective hepatic iron
sensing, as indicated by low HJV expression. TNF- appears to play a
role in exerting these regulatory changes. Increased hepcidin
formation in iron-overloaded NAFLD patients, however, results in
decreased duodenal FP-1 expression, whereas a reduction in liver FP-1
may perpetuate hepatic iron retention. Phlebotomy offers a safe and
efficient therapy for these metabolic disturbances.


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk





Reply from: ironjustice
Date: 10 May, 05:53
On May 9, 5:34 pm, ironjustice <teamtan...@hotmail.com>
wrote:"Phlebotomy offers a safe and efficient therapy" <<

NAFLD may be present to some extent in "just about everybody."

http://care.diabetesjournals.org/cgi/content/full/26/4/1297


Who loves ya.
Tom


Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh


Man Is A Herbivore!
http://tinyurl.com/a3cc3


DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk

> "Phlebotomy offers a safe and efficient therapy"
>
> American Journal of Clinical Nutrition, Vol. 87, No. 5, 1374-1383, May
> 2008
> © 2008 American Society for Nutrition
>
> --------------------------------------------------------------------------=
------
>
> ORIGINAL RESEARCH COMMUNICATION
>
> Pathways underlying iron accumulation in human nonalcoholic fatty
> liver disease1,2,3
> Elmar Aigner, Igor Theurl, Milan Theurl, Dieter Lederer, Heike Haufe,
> Otto Dietze, Michael Strasser, Christian Datz and Guenter Weiss
> 1 From the Department of Internal Medicine, General Hospital
> Oberndorf, Oberndorf, Austria (EA, DL, and CD); the Department of
> General Internal Medicine, Department of Immunology and Infectious
> Diseases, Medical University of Innsbruck, Austria (IT, MT, and GW);
> the Department of Pathology (HH and OD) and the First Department of
> Medicine (MS), Paracelsus Private Medical University Salzburg,
> Austria
>
> Background: Mild iron overload is frequently observed in nonalcoholic
> fatty liver disease (NAFLD).
>
> Objective: We aimed to study putative pathways underlying iron
> accumulation in NAFLD.
>
> Design: Hepatic and duodenal expression of critical iron molecules in
> NAFLD patients with (n = 32) and without (n = 29) iron overload,
> hereditary hemochromatosis (n = 10), and controls (n = 20) were
> investigated. Phlebotomy treatment was performed in 14 NAFLD
> patients.
>
> Results: The hepatic expressions of the iron-export protein
> ferroportin-1 (FP-1) and of the iron-sensing molecule hemojuvelin
> (HJV) were significantly lower in NAFLD patients. The mRNA expression
> of the iron-regulatory peptide hepcidin was increased in NAFLD
> patients with iron overload, which was paralleled by low duodenal FP-1
> expression. Hepatic mRNA and serum protein concentrations of tumor
> necrosis factor- (TNF-) were increased in NAFLD patients and were
> inversely correlated with both liver FP-1 and HJV mRNA and positively
> associated with body mass index and hepatic hepcidin mRNA.
> Accordingly, TNF- inhibited the FP-1 and HJV mRNA formation in HepG2
> cells. Phlebotomy treatment of NALFD patients reduced serum ferritin,
> transferrin saturation, and TNF- concentrations and improved liver
> function tests.
>
> Conclusions: Iron accumulation in NAFLD may result from an impaired
> iron export due to down-regulation of FP1 and ineffective hepatic iron
> sensing, as indicated by low HJV expression. TNF- appears to play a
> role in exerting these regulatory changes. Increased hepcidin
> formation in iron-overloaded NAFLD patients, however, results in
> decreased duodenal FP-1 expression, whereas a reduction in liver FP-1
> may perpetuate hepatic iron retention. Phlebotomy offers a safe and
> efficient therapy for these metabolic disturbances.
>
> Who loves ya.
> Tom
>
> Jesus Was A Vegetarian!http://tinyurl.com/2r2nkh
>
> Man Is A Herbivore!http://tinyurl.com/a3cc3
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk





Login:
  Username:    Password: 
 
   Lost Password? click here!
Thread: